FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3125747668> ?p ?o ?g. }

• W3125747668 abstract "Abstract Breast cancer (BC) is the most common malignancy among women. Mesenteric estrogen-dependent adipogenesis gene (MEDAG) was first reported as a novel adipogenic gene, and its involvement and mechanism in visceral adiposity were analyzed. However, the role of MEDAG in BC is unclear. The biological roles and corresponding mechanisms were investigated in vitro and in vivo. We found that MEDAG was highly expressed in BC samples and that a high MEDAG expression was correlated with clinicopathological characteristics and poor survival in BC patients. MEDAG knockdown inhibited cell proliferation, invasion, and migration; triggered epithelial-to-mesenchymal transition (EMT); and enhanced epirubicin sensitivity in vitro. The opposite results were observed in MEDAG-overexpressing cells. The inhibition of MEDAG suppressed tumor growth and metastasis in vivo. Mechanistically, MEDAG knockdown led to decreased phosphorylation levels of AKT, increased levels of p-AMPK, and reduced levels of p-mTOR, while the overexpression of MEDAG had the opposite effects. Moreover, the activation of p-AKT and inhibition of p-AMPK restored the effect of MEDAG on EMT and chemosensitivity in BC cell lines, indicating that MEDAG functions as an oncogene by regulating the AKT/AMPK/mTOR pathway. MEDAG regulates BC progression and EMT via the AKT/AMPK/mTOR pathway and reduces chemosensitivity in BC cells. Therefore, MEDAG is a promising target for BC." @default.
• W3125747668 created "2021-02-01" @default.
• W3125747668 creator A5002695529 @default.
• W3125747668 creator A5020438767 @default.
• W3125747668 creator A5023494462 @default.
• W3125747668 creator A5045934445 @default.
• W3125747668 creator A5046855922 @default.
• W3125747668 creator A5072825980 @default.
• W3125747668 creator A5073681238 @default.
• W3125747668 creator A5082626123 @default.
• W3125747668 creator A5086475800 @default.
• W3125747668 date "2021-01-18" @default.
• W3125747668 modified "2023-10-12" @default.
• W3125747668 title "MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway" @default.
• W3125747668 cites W1495274944 @default.
• W3125747668 cites W1974643611 @default.
• W3125747668 cites W1981394514 @default.
• W3125747668 cites W2006771504 @default.
• W3125747668 cites W2007095168 @default.
• W3125747668 cites W2023906705 @default.
• W3125747668 cites W2028593825 @default.
• W3125747668 cites W2042619042 @default.
• W3125747668 cites W2081920342 @default.
• W3125747668 cites W2087367170 @default.
• W3125747668 cites W2102707911 @default.
• W3125747668 cites W2104546896 @default.
• W3125747668 cites W2113860186 @default.
• W3125747668 cites W2115792588 @default.
• W3125747668 cites W2127063807 @default.
• W3125747668 cites W2137530154 @default.
• W3125747668 cites W2165200432 @default.
• W3125747668 cites W2341927347 @default.
• W3125747668 cites W2415913163 @default.
• W3125747668 cites W2462715093 @default.
• W3125747668 cites W2555771555 @default.
• W3125747668 cites W2606001457 @default.
• W3125747668 cites W2765494008 @default.
• W3125747668 cites W2804730677 @default.
• W3125747668 cites W2885969267 @default.
• W3125747668 cites W2938984682 @default.
• W3125747668 cites W2999417355 @default.
• W3125747668 doi "https://doi.org/10.1038/s41419-020-03340-w" @default.
• W3125747668 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7814033" @default.
• W3125747668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33462219" @default.
• W3125747668 hasPublicationYear "2021" @default.
• W3125747668 type Work @default.
• W3125747668 sameAs 3125747668 @default.
• W3125747668 citedByCount "15" @default.
• W3125747668 countsByYear W31257476682021 @default.
• W3125747668 countsByYear W31257476682022 @default.
• W3125747668 countsByYear W31257476682023 @default.
• W3125747668 crossrefType "journal-article" @default.
• W3125747668 hasAuthorship W3125747668A5002695529 @default.
• W3125747668 hasAuthorship W3125747668A5020438767 @default.
• W3125747668 hasAuthorship W3125747668A5023494462 @default.
• W3125747668 hasAuthorship W3125747668A5045934445 @default.
• W3125747668 hasAuthorship W3125747668A5046855922 @default.
• W3125747668 hasAuthorship W3125747668A5072825980 @default.
• W3125747668 hasAuthorship W3125747668A5073681238 @default.
• W3125747668 hasAuthorship W3125747668A5082626123 @default.
• W3125747668 hasAuthorship W3125747668A5086475800 @default.
• W3125747668 hasBestOaLocation W31257476681 @default.
• W3125747668 hasConcept C11960822 @default.
• W3125747668 hasConcept C121608353 @default.
• W3125747668 hasConcept C122927707 @default.
• W3125747668 hasConcept C126322002 @default.
• W3125747668 hasConcept C173396325 @default.
• W3125747668 hasConcept C185592680 @default.
• W3125747668 hasConcept C198826908 @default.
• W3125747668 hasConcept C2779013556 @default.
• W3125747668 hasConcept C2780124434 @default.
• W3125747668 hasConcept C2780835546 @default.
• W3125747668 hasConcept C2781018059 @default.
• W3125747668 hasConcept C29537977 @default.
• W3125747668 hasConcept C502942594 @default.
• W3125747668 hasConcept C530470458 @default.
• W3125747668 hasConcept C54355233 @default.
• W3125747668 hasConcept C55493867 @default.
• W3125747668 hasConcept C62112901 @default.
• W3125747668 hasConcept C62478195 @default.
• W3125747668 hasConcept C71924100 @default.
• W3125747668 hasConcept C75217442 @default.
• W3125747668 hasConcept C76419328 @default.
• W3125747668 hasConcept C81885089 @default.
• W3125747668 hasConcept C86554907 @default.
• W3125747668 hasConcept C86803240 @default.
• W3125747668 hasConcept C95444343 @default.
• W3125747668 hasConcept C97029542 @default.
• W3125747668 hasConceptScore W3125747668C11960822 @default.
• W3125747668 hasConceptScore W3125747668C121608353 @default.
• W3125747668 hasConceptScore W3125747668C122927707 @default.
• W3125747668 hasConceptScore W3125747668C126322002 @default.
• W3125747668 hasConceptScore W3125747668C173396325 @default.
• W3125747668 hasConceptScore W3125747668C185592680 @default.
• W3125747668 hasConceptScore W3125747668C198826908 @default.
• W3125747668 hasConceptScore W3125747668C2779013556 @default.
• W3125747668 hasConceptScore W3125747668C2780124434 @default.
• W3125747668 hasConceptScore W3125747668C2780835546 @default.
• W3125747668 hasConceptScore W3125747668C2781018059 @default.
• W3125747668 hasConceptScore W3125747668C29537977 @default.

• next